New York – July 26, 2016 – Cooley advised the underwriters on Syros Pharmaceuticals' $57.5 million initial public offering. The company's common stock now trades on The NASDAQ Global Select Market under the symbol "SYRS."
Cowen and Company and Piper Jaffray & Co. acted as joint book-running managers for the offering. JMP Securities acted as lead manager for the offering, and Wedbush PacGrow acted as co-manager for the offering.
Syros is a biopharmaceutical company pioneering the understanding of the non-coding region of the genome to advance a new wave of medicines that control expression of disease-driving genes.
The Cooley corporate and securities team advising the underwriters included Div Gupta, Nicole Brookshire, Rich Segal, Barbara Bispham, Esther Cho and Layne Jacobs.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 900 lawyers across 12 offices in the United States, China and Europe.